A Phase I study of granulocyte-macrophage-colony stimulating factor/interleukin-3 fusion protein (PIXY321) following ifosfamide, carboplatin, and etoposide therapy for children with recurrent or refractory solid tumors: a report of the Children's Cancer G
A Phase I study of granulocyte-macrophage-colony stimulating factor/interleukin-3 fusion protein (PIXY321) following ifosfamide, carboplatin, and etoposide therapy for children with recurrent or refractory solid tumors: a report of the Children's Cancer G
复制标题
异环磷酰胺、卡铂和依托泊苷治疗复发性或难治性实体瘤儿童后粒细胞-巨噬细胞-集落刺激因子/白细胞介素 3 融合蛋白 (PIXY321) 的 I 期研究：儿童癌症 G 的报告
作者：
Cairo,MS;Krailo,MD;Weinthal,JA;Secola,R;Bergeron,S;vandeVen,C;Blazar,BR;Garrison,L;Reaman,GH
